China might be winning the CRISPR race, but we have the FDA
Posted by btwatson on January 30, 2018 8:06 pm
Tags:
Categories:
Crispr Articles
Source: China might be winning the CRISPR race, but we have the FDA
Proper drug labelling and safety only came after unfortunate circumstances.
Published at Tue, 30 Jan 2018 20:03:10 +0000
Crispr News
-
Chinese creator of first gene-edited humans says ‘we should respect them’ - South China Morning PostFebruary 7, 2023
-
Bill Gates Excited About Future Of CRISPR Gene-Editing Tech - BenzingaFebruary 7, 2023
-
Gene Editing: CRISPR Therapeutics vs. Beam Therapeutics - Securities.ioFebruary 6, 2023
-
Marketing study of sickle cell patients looks at effects of racism on ... - UIC TodayFebruary 6, 2023
-
Scientists introduced alligator DNA into catfish to create hybrid - Interesting EngineeringFebruary 6, 2023
-
3 Cathie Wood Stocks Wall Street Thinks Can Soar 60% to 129% - The Motley FoolFebruary 6, 2023
-
CRISPR Cas9 Market Quantitative and Qualitative Analysis 2023 ... - Digital JournalFebruary 6, 2023
-
iotaSciences Launches New isoPick™ Single-Cell Picker to Further ... - PharmiWeb.comFebruary 6, 2023
-
China Planning To Ban Gene Editing Technology Exports - ScripFebruary 6, 2023
-
Zinc fingers: New AI-powered biotech innovation could offer unique ... - Genetic Literacy ProjectFebruary 6, 2023
-
Spatial CRISPR Genomics of Tumor Microenvironments - Genetic Engineering & Biotechnology NewsFebruary 6, 2023
-
The science behind colorful snakes - study - The Jerusalem PostFebruary 4, 2023
-
3 No-Brainer Growth Stocks to Buy in 2023 - The Motley FoolFebruary 3, 2023
-
Why Editas Medicine's Shares Jumped This Week - NasdaqFebruary 3, 2023
-
‘Self-harm and decay are not inevitable': This 45-year-old tech mogul spends $2M per year to get an '18-year-old body' — here are 3 top anti-aging stocks to watch now - Yahoo FinanceFebruary 3, 2023
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.